SLIRP: A Non-Coding RNA-Binding Protein (G81892)

Target Name: SLIRP

NCBI ID: G81892

SLIRP

SLIRP: A Non-Coding RNA-Binding Protein

SLIRP (stem-loop interacting RNA binding protein) is a protein that plays a critical role in RNA biology and is widely expressed in various cell types. It is a non-coding RNA-binding protein that consists of a single polypeptide chain of 184 amino acids acids. SLIRP is primarily localized to the endoplasmic reticulum (ER) and is involved in various cellular processes, including cell signaling, DNA replication, and gene expression.

SLIRP is a protein that interacts with RNA through its stem-loop structure. The stem-loop is a common structural motif that is found in the 5' end of many RNA molecules. It is a platform for various RNA-binding proteins to interact with RNA and is involved in the regulation of gene expression. The stem-loop interacts with SLIRP through a conserved sequence that is present in the 5' end of many RNA molecules.

SLIRP is a member of the SLIRP/RNA-binding domain (SLIRP/RBD) family, which includes several proteins that share a similar stem-loop structure and function. These proteins include ZF-IP3, Dynaminin-like, and miRNA -20. The SLIRP/RBD family is thought to have evolved from a common ancestor protein that was involved in the regulation of gene expression.

SLIRP is involved in many cellular processes, including cell signaling, DNA replication, and gene expression. It is involved in the regulation of cell cycle progression, cell division, and the progression of the cell. It is also involved in the regulation of cell survival and apoptosis.

SLIRP is a potential drug target and may be a biomarker for various diseases.SLIRP has been shown to play a role in the regulation of cancer cell growth and has been used as a therapeutic agent in various clinical trials. For example, a SLIRP inhibitor has has been shown to inhibit the growth of cancer cells and to increase the rate of apoptosis in these cells.

SLIRP is also a potential biomarker for various diseases, including cancer.SLIRP has been shown to be expressed in various types of cancer and has been used as a potential biomarker for cancer diagnosis and treatment. For example, a SLIRP gene expression profile has been shown to be altered in various types of cancer and may be a useful biomarker for cancer diagnosis and treatment.

SLIRP is a highly conserved protein that is found in many different cell types. It is conserved at the 3' end (end) and 5' end (terminal) of chromosomes (chromosomes). The function and structure of SLIRP suggest that it may be useful in biomedical research plays an important role in. Research on SLIRP will help understand the role of SLIRP in biomedical research and develop

Protein Name: SRA Stem-loop Interacting RNA Binding Protein

Functions: RNA-binding protein that acts as a nuclear receptor corepressor. Probably acts by binding the SRA RNA, and repressing the SRA-mediated nuclear receptor coactivation. Binds the STR7 loop of SRA RNA. Also able to repress glucocorticoid (GR), androgen (AR), thyroid (TR) and VDR-mediated transactivation

The "SLIRP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLIRP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets